Isoniazid (DrugBank: Isoniazid)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 254 | ポルフィリン症 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01550705 (ClinicalTrials.gov) | March 2012 | 5/3/2012 | Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria | Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria | Erythropoietic Protoporphyria (EPP);X Linked Erythropoietic Protoporphyria | Drug: Isoniazid | University of Utah | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Icahn School of Medicine at Mount Sinai;University of Alabama at Birmingham;University of California, San Francisco;University of Texas | Terminated | 18 Years | N/A | All | 11 | N/A | United States |